Irodalomjegyzék
1. Grauvogel J, Daemmrich TD, Ryschich E, et al: Chronic alcohol intake increases the
severity of pancreatitis induced by acute alcohol administration, hyperlipidaemia and
pancreatic duct obstruction in rats. Pancreatology 2010; 10: 603-612
2. Koh YH, Tamizhselvi R, Moochhala S, et al: Role of protein kinase C in caerulein induced
expression of substance P and neurokinin-1 receptors in murine pancreatic acinar cells. J.Cell
Mol Med 2010; PMD 20973912
3. Nakada S, Tsuneyama K, Kato I, et al: Identification of candidate genes involved in
endogenous protection mechanisms againts acute pancreatitis in mice. Biochem Biophys Res
Commun 2010; 391:1342-1347
4. Zhou H, Liu L, Bai Y, et al: Damage of the interstitial cells of Cajal and myenteric neurons
causing ileus in acute necrotising pancreatitis rats. Surgery 2011; 149:262-275
5. Ulmasov B, Xu Z, Talkad V, et al.: Angiotensin II signaling through the AT-1a and AT-1b
receptors does not have a role in the development of cerulein induced chronic pancreatitis in
the mouse. Am J Physiol Gastrointest Liver Physiol 2010; 299: G70-80
6. Khan1 AS, Latif SU, Eloubeidi MA: Controversies in the Etiologies of Acute Pancreatitis. J
Pancreas (Online) 2010; 11: 545-552
7. Andersson B, Ansari D, Andersson E, et al: Fatal acute pancreatitis occuring outside of the
hospital: clinical and social characteristics. World J Surg 2010; 34:2286-2291
8. Barreto SG, Saccone GT: Alcohol-induced acute pancreatitis: the „Critical mass” concept.
Med Hypotheses 2010; 75: 73-76
9. Enge SS, Williams-Herman DE, Golm GT, et al: Sitagliptin: review of preclinical and
clinical data regarding incidence of pancreatitis. Int J Clin Pract 2010; 64: 984-990
10. Ocal1 S, Selcuk1 H, Korkmaz1 M, et al: Acute Pancreatitis Following Doxycycline and
Ornidazole Coadministration. J Pancreas (Online) 2010; 11: 614-616
11. Slim R, Ben Salem C, Zamy M, et al: Secnidazole-Induced Acute Pancreatitis:A New
Side-Effect for an Old Drug? J Pancreas (Online) 2010; 11: 85-86
12. Ahmad FA, Mahmud S: Acute Pancreatitis Following Orlistat Therapy: Report of Two
Cases. J Pancreas (Online) 2010; 11: 61-63
13. Elouni1 B, Ben Salem C, Zamy1 M et al: Bortezomib-Induced Acute Pancreatitis. J
Pancreas (Online) 2010; 11: 275-276
14. Saadati H, Wasif M: Sorafenib-Induced Acute Pancreatitis. J Pancreas (Online) 2010; 11:
283-284
15. Pezzilli1 R, Corinaldesi1 R, Morselli-Labate AM: Tyrosine Kinase Inhibitors and Acute
Pancreatitis. J Pancreas (Online) 2010; 11: 291-293
16. Sakhri1 J, Ben Salem C, Harbi1 H, et al: Severe Acute Pancreatitis Due to TamoxifenInduced Hypertriglyceridemia with Positive Rechallenge. J Pancreas (Online) 2010; 11: 382-
384
17. Chong VH, Basir N, Yaakub AB: Acute Pancreatitis Complicated by Jejunal Hematoma in
a Patient on Anti-Coagulants and Anti-Platelets. J Pancreas (Online) 2010; 11: 262-265
18. Piton G, Barbot O, Manzon C, et al: Acute Ischemic Pancreatitis Following Cardiac
Arrest: A Case Report. J Pancreas (Online) 2010; 11: 456-459
19. Verma1 R, Dhamija R, Ross1 SC, et al: Symbiotic Bacteria Induced Necrotizing
Pancreatitis. J Pancreas (Online) 2010; 11: 474-476
20. Diop SP, Costi R, Bian AL, et al. Acute pancreatitis associated with pancreatic hydatid
cyst: understanding the mechanism by EUS. Gastrointest Endosc 2010; 72: 1312-1314.
21. Leelakusolvong S, Sriprayoon T, Methasate A, et al. Endoscopic treatment of acute
Ascaris pancreatitis. Endoscopy 2010; 42 Suppl 2: E12-13.
22. Shah1 OJ, Robbani I, Zargar SA et al: Hydatid Cyst of the Pancreas. An Experience with
Six Cases. J Pancreas (Online) 2010; 11: 575-581
23. Javed1 A, Pal1 S, Chaubal1 GN et al: Unusual Cystic Lesion of the Pancreas. J Pancreas
(Online) 2010; 11: 401-402
24. Rana SS, Bhasin DK, Rao C: Isolated Pancreatic Tuberculosis Mimicking Focal
Pancreatitis and Causing Segmental Portal Hypertension. J Pancreas (Online) 2010; 11:393-
395
25. Chong1 VH, Lim KS, Sharif F: Pancreatic Involvement in Melioidosis. J Pancreas
(Online) 2010; 11: 365-368
26. Mariani A: Chronic Asymptomatic Pancreatic Hyperenzymemia:Is It a Benign Anomaly
or a Disease? J Pancreas (Online) 2010; 11: 95-98
27. Shah1 AM, Eddi R, Kothari ST et al: Acute Pancreatitis with Normal Serum Lipase: A
Case Series. J Pancreas (Online) 2010; 11: 369-372
28. Daniel P, Lerniowski B, Mokrowiecka A, et al: Circulating levels of visfatin, resistin and
proinflammatory cytokine interleukin-8 in acute pancreatitis. Pancreatology 2010; 10: 477-
482
29. Chakraborty S, Kaur S, Muddana V, et al: Elevated serum neutrophil gelatinase –
associated lipocalin is an early predictor of severity and outcome in acute pancreatitis Am J
Gastroenterol 2010; 105:2050-2059
30. Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis J
Hepatobiliary Pancreat Sci (2010) 17:24–36
31. Préau S, Saulnier F, Dewavrin F, et al.: Passive leg raising is predictive of fluid
responsiveness in spontaneously breathing patients with severe sepsis or acute pancreatitis.
Crit Care Med 2009;38:819-825
32. Khaliq A, Dutta U, Kochhar R, et al: Management of Acute Pancreatitis: “PANCREAS”
Contains Eight Easy Steps to Remember the Treatment. J Pancreas (Online) 2010; 11: 492-
493
33. Pezzili R, Zerbi A, Di Carlo V, et al: Practical guidelines for acute pancreatitis.
Pancreatology 2010; 10:523-535
34. Sakorafas GH, Lapas C, Mastoraki A, et al: Current trends in the management of infected
necrotizing pancreatitis. Infect Disord Drug Targets 2010; 10: 9-14
35. Bragg1 JD, Cox KR, Despins L et al: Improvements in Care in Acute Pancreatitis by the
Adoption of an Acute Pancreatitis Algorithm. J Pancreas (Online) 2010; 11: 183-185
36. Ross A, Gluck M, Irani S, et al.: Combined endoscopic and percutaneous drainage of
organized pancreas necrosis. Gastrointest Endosc 2010; 71: 79-84.
37. Belle S, Collet P, Post S, et al. Temporary cystogastrostomy with self-expanding metallic
stents for pancreatic necrosis. Endoscopy 2010; 42: 493-495.
38. Tarantino I, Traina M, Barresi L, et al. Transgastric plus transduodenal necrosectomy
with temporary metal stents placement for treatment of large pancreatic necrosis. Pancreas.
2010; 39: 269-270.
39. Wig1 JD, Gupta1 V, Kochhar R: The Role of Non-Operative Strategies in the
Management of Severe Acute Pancreatitis. J Pancreas (Online) 2010; 11: 553-559
40. Rana SS, Bhasin DK, Nanda M, et al. Endoscopic transpapillary drainage for external
fistulas developing after surgical or radiological pancreatic interventions. J Gastroenterol
Hepatol. 2010; 25: 1087-1092.
41. Amano H, Takada T, Isaji S, et al. Therapeutic intervention and surgery of acute
pancreatitis J Hepatobiliary Pancreat Sci (2010) 17:53–59
42. Petrov MS, Shanbhag S, Chakraborty, et al.: Organ failure and infection of pancreatic
necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology.
2010;139:813-20
43. van Santvoort HC, Besselink MG, Bakker OJ, et al.: A step-up approach or open
necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362:1491-502
44. Raraty MG, Halloran CM, Dodd S, et al: Minimal access retroperitoneal pancreatic
necrosectomy: improvement in morbidity and mortality with a less invasive approach. Ann
Surg. 2010;251:787-93
45. Babu BI; Sheen AJ, Lee SH, et al.: Open pancreatic necrosectomy in the multidisciplinary
management of postinflammatory necrosis. Ann Surg. 2010;251:783-6
46. Dong Z, Petrov MS, Xu J, et al.: Peritoneal lavage for severe acute pancreatitis: a
systematic review of randomised trials. World J Surg. 2010;34:2103-8
47. Al-Azzawi HH, Kuhlenschmidt H, Howard TJ, et al.: The burden of incisional hernia in
necrotizing pancreatitis: how can we improve? Am J Surg. 2010;199:310-4
48. Andersson E, Ansari D, Andersson R.: Major haemorrhagic complications of acute
pancreatitis. Br J Surg. 2010;97:1379-84
49. Aboulian A, Chan T, Yaghoubian A, et al.: Early cholecystectomy safely decreases
hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study.
Ann Surg. 2010;251:615-9
50. Schneider A, Larusch J, Sun X, et al: Combined bicarbonate conductance – impairing
variants in CFTR and SPINK1 are associated with chronic pancreatitis in patients without
cystic fibrosis. Gastroenterology 2011; 140:162-171
51. Khuroo1 N S, Khuroo1 M S, Khurool M S: Anomalous Pancreaticobiliary Ductal Union in
Tropical Calcific Pancreatitis. J Pancreas (Online) 2010; 11:18-24
52. Saluja SS, Mishra PK, Nayeem M, et al: Choledochal Cyst with Chronic Pancreatitis:
Presentation and Management. J Pancreas (Online) 2010; 11: 601-603
53. Podborska M, Sevcikova A, Trna J, et al: Increaased markers of oxidative stress in plasma
of patients with chronic pancreatitis. Neuro Endocrinol Lett 2009; 30(suppl): 116-120
54. Sunnapwar A, Prasad SR, Menias CO, et al. Nonalcoholic, Nonbiliary Pancreatitis:
Cross-Sectional Imaging Spectrum AJR 2010
55. Stevens T, Parsi MA. Endoscopic ultrasound for the diagnosis of chronic pancreatitis.
World J Gastroenterol. 2010; 16: 2841-2850.
56. Stevens T, Lopez R, Adler DG, et al. Multicenter comparison of the interobserver
agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of
chronic pancreatitis. Gastrointest Endosc 2010; 71: 519-526.
57. Balci NC, Smith A, Momtahen AJ, et al. MRI and S-MRCP Findings in Patients With
Suspected Chronic Pancreatitis: Correlation With Endoscopic Pancreatic Function Testing
(ePFT) JOURNAL OF MAGNETIC RESONANCE IMAGING 31:601–606 (2010)
58. Braganza JM, Dormandy TL: Micronutrient Therapy for Chronic Pancreatitis: Rationale
and Impact. J Pancreas (Online) 2010; 11: 99-112
59. Rajesh1 G, Girish BN, Vaidyanathan K et al: Folate Deficiency in Chronic Pancreatitis. J
Pancreas (Online) 2010; 11: 409-410
60. Braganza JM: Reply to ‘Folate Deficiency in Chronic Pancreatitis’. J Pancreas (Online)
2010; 11: 413-414
61. Wagner C: Some More Comments on ‘Folate Deficiency in Chronic Pancreatitis’.
J Pancrea (Online) 2010; 11: 646-647
62. Rajesh1 G, Girish BN, Vaidyanathan K, et al: Reply to ‘Some More Comments on Folate
Deficiency in Chronic Pancreatitis’. J Pancreas (Online) 2010; 11: 652-653
63. Marosvölgyi T, Horváth G, Dittrich A, et al: Fatty acid composition of plasma lipid
classes in chronic alcoholic pancreatitis. Pancreatology 2010; 10: 580-585
64. Domínguez-Munoz. JE, Iglesias-García J: Oral Pancreatic Enzyme Substitution Therapy
in Chronic Pancreatitis: Is Clinical Response an Appropriate Marker for Evaluation of
Therapeutic Efficacy? J Pancreas (Online) 2010; 11: 158-162
65. Knop1 FK, Vilsboll T, Lund1 A, et al: The Impact of Pancreatic Enzyme Supplementation
on Postprandial Responses of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis
and Pancreatic Exocrine Insufficiency. J Pancreas (Online) 2010; 11: 489-491
66. Lawrence C, Siddiqi MF, Hamilton JN, et al. Chronic calcific pancreatitis: combination
ERCP and extracorporeal shock wave lithotripsy for pancreatic duct stones. South Med J.
2010; 103: 505-508. Comment in:South Med J. 2010; 103: 494-495.
67. Parsi MA, Stevens T, Lopez R, et al. Extracorporeal shock wave lithotripsy for prevention
of recurrent pancreatitis caused by obstructive pancreatic stones. Pancreas. 2010; 39: 153-155.
68. Moon SH, Kim MH, Park dH et al. Modified fully covered self-expanded metal stents
with antimigration features for benign pancreatic-duct strictures in advanced chronic
pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc
2010; 72: 86-91.
69. Binmoeller KF. Fully covered metal stents in the pancreatic duct: balancing trade-offs.
Gastrointest Endosc. 2010; 72: 92-4.Comment on:Gastrointest Endosc. 2010; 72: 86-91.
70. Itoi T, Sofuni A, Itokawa F, et al. Transpapillary incision of refractory circumscript
pancreatic duct stricture using wire-guided snare forceps. World J Gastroenterol. 2010; 16:
1541-1544.
71. Li ZS, Wang W, Liao Z, et al. A long-term follow-up study on endoscopic management of
children and adolescents with chronic pancreatitis. Am J Gastroenterol. 2010; 105: 1884-1892.
72. Cavallini A, Butturini G, Malleo G, et al. Endoscopic transmural drainage of pseudocysts
associated with pancreatic resections or pancreatitis: a comparative study. Surg Endosc. 2010
Oct 26. [Epub ahead of print]
73. Trevino JM, Tamhane A, Varadarajulu S. Successful stenting in ductal disruption
favorably impacts treatment outcomes in patients undergoing transmural drainage of
peripancreatic fluid collections. J Gastroenterol Hepatol. 2010; 25: 526-531. Comment in:J
Gastroenterol Hepatol. 2010; 25: 433-434.
74. Bhasin DK, Rana SS. Combining transpapillary pancreatic duct stenting with endoscopic
transmural drainage for pancreatic fluid collections: two heads are better than one! J
Gastroenterol Hepatol. 2010; 25: 433-434.Comment on:J Gastroenterol Hepatol. 2010; 25:
526-531.
75. Varadarajulu S, Trevino J, Wilcox CM, et al. Randomized trial comparing EUS and
surgery for pancreatic pseudocyst drainage. Gastrointest Endosc 2010; 71: AB116.
76. Kim J, Shah JN, Marson F, et al. Self-expandable metal stent without dilatation for
drainage of pancreatic fluid collection using a front-view forward-array echoendoscope.
Gastrointest Endosc 2010; 71: AB282.
77. Evans JA, Conway JD, Mishra G. A novel method for performing multiple wire insertion
during endoscopic cyst gastrostomy. Gastrointest Endosc 2010; 71: 612-614.
78. Theodoros D, Nikolaides P, Petousis G. Ultrasound-guided endoscopic transgastric
drainage of a post-traumatic pancreatic pseudocyst in a child. Afr J Paediatr Surg 2010; 7:
194-196.
79. Karvonen J, Gullichsen R, Salminen P, et al. Endoscopic treatment of pseudocystocolonic
fistula by fibrin glue. Gastrointest Endosc 2010; 72: 664-665.
80. Noh R, Kim HJ. A pancreatic pseudocyst-portal vein fistula closed by endoscopic
pancreatic stent insertion. Gastrointest Endosc 2010; 72: 1103-1105.
81. Kibria R, Akram S, Ali SA. Successful endoscopic transpapillary management of
intrahepatic pancreatic pseudocyst. JOP. 2010; 11: 41-44.
82. Honda H, Miyatani H, Ikeya T, et al. Endoscopic ultrasound-guided transmural cyst
drainage (EUS-CD) was effective in a case of pancreatic pseudocyst with obstructive jaundice
and duodenal stenosis. Nippon Shokakibyo Gakkai Zasshi. 2010; 107: 1497-1504.
83. Ergun M, Descamps C, Deprez PH. Per oral dual-scope rendezvous technique for
endoscopic bridging of complete pancreatic duct disruption. Endoscopy. 2010;42 Suppl 2:
E275-6.
84. Cai Q, Keilin S, Obideen K, et al. Intraduodenal hydrochloric acid infusion for facilitation
of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a
preliminary study. Am J Gastroenterol. 2010; 105: 1450-1451.
85. Barkay O, Sherman S, McHenry L, et al. Therapeutic EUS-assisted endoscopic retrograde
pancreatography after failed pancreatic duct cannulation at ERCP. Gastrointest Endosc 2010;
71: 1166-1173.
86. Cooper ST, Malick J, McGrath K, et al. EUS-guided rendezvous for the treatment of
pancreaticopleural fistula in a patient with chronic pancreatitis and pancreas pseudodivisum.
Gastrointest Endosc 2010; 71: 652-654.
87. Das K, Kitano M, Komaki T, et al. Pancreatic ductal drainage by endoscopic ultrasoundassisted rendezvous technique for pain caused by ductal stricture with chronic pancreatitis.
Dig Endosc. 2010; 22: 217-219.
88. Wilkinson M, Nagula S, Buscaglia JM. Spiral enteroscopy-assisted pancreatoscopy for the
diagnosis for obscure overt bleeding in a patient with surgically altered anatomy. Gastrointest
Endosc 2010; 72: 653-655.
89. Ryou M, Mullady DK, Dimaio CJ, et al. Pancreatic antegrad needle knife for treatment for
symptomatic pancreatic duct obstruction in Whipple patient. Gastrointest Endosc 2010; 72:
1081-1088.
90. Ota Y, Kikuyama M, Suzuki S, et al. Percutaneous pancreatic-duct puncture with
rendezvous technique can treat stenotic pancreaticojejunostomy. Dig Endosc. 2010; 22: 228-
231.
91. Nambu T, Ukita T, Shigoka H, et al. Endoscopic retrieval of a disrupted pancreatic stent
using a nasopancreatic drainage tube. Endoscopy. 2010; 42 Suppl 2: E308-9.
92. Vila JJ, Ruiz-Clavijo D, Fernández-Urién I, et al. Endoscopic retrieval of a proximally
migrated pancreatic stent: variation of the lasso technique. Endoscopy 2010; 42 Suppl 2: E5-6.
93. Cantillon-Murphy P, Ryou M, Shaikh SN, et al. A magnetic retrieval system for stents in
the pancreaticobiliary tree. IEEE Trans Biomed Eng. 2010; 57: 2018-2025.
94. Seicean A, Stan-Iuga R, Munteanu D. An unusual cause of hemosuccus pancreaticus
diagnosed by endoscopic ultrasonography: splenic arterial fistula due to a pancreatic stent
(with video). Endoscopy. 2010; 42 Suppl 2: E239-40.
95. Negi S, Singh A, Chaudhary A.: Pain relief after Frey’s procedure for chronic pancreatitis.
Br J Surg. 2010;97:1087-95
96. Farkas G, Leindler L, Daróczi M., et al.: Ten-year experience with duodenum and organpreserving pancreatic head resection (Büchler-Farkas modification) in the surgical treatment
of chronic pancreatitis. Pancreas. 2010;39:1082-7
97. van Loo ES, van Baal MC, Gooszen HG, et al.: Long-term quality of life after surgery for
chronic pancreatitis. Br J Surg. 2010;97:1079-86
98. Gardner TB, Kennedy AT, Gelrud A, et al.: Chronic pancreatitis and its effect on
employment and health care experience: results of a prospective American multicenter study.
Pancreas. 2010;39:498:501
99. Takita M, Naziruddin B, Matsumoto S et al: Body mass index reflects islet isolation
outcome in islet autotransplantation for patients with chronic pancreatitis. Cell Transplant
2010; PMD 20719073
100. Forcione DG et Brugge WR. New kid on the block? Autoimmune pancreatitis Clin
gastroenterol 2010;24:361-378.
101. Moon SH et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be
useful for supporting a diagnosis of autoimmune pancreatitis Gastrointest Endosc
2010;71:960-966.
102. Jesnowski R et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic
carcinoma Pancreatology 2010;10:462-466.
103. Löhr JM, Faissner R, Koczan D, et al: Autoantibodies against the exocrine pancreas in
autoimmune pancreatitis, gene and protein expression profiling and immunoassays identify
pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol 2010;
105:2060-2071
104. Hirano K, Tada M, Isayama H, et al. Endoscopic evaluation of factors contributing to
intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc 2010; 71: 85-
90.
105. Pezzilli R, Corinaldesi R: Autoimmune Pancreatitis, Pancreatic Cancer and
Immunoglobulin-G4. J Pancreas (Online) 2010; 11: 89-90.
106. Suzuki K , Itoh S, Nagasaka T,et al.. CT findings in autoimmune pancreatitis:
assessment using multiphase contrast-enhanced multisection CT Clinical Radiology 65 (2010)
735e743
107. Nakazawa1 T, Naitoh1 I, Ando1 T, et al: Autoimmune Pancreatitis not Responsive to
Steroid Therapy. J Pancreas (Online) 2010; 11: 58-60
108. Goldsmith PJ, Cockbain AJ, Smith AM: Spontaneous Resolution of Pulmonary Nodules
in Autoimmune Pancreatitis. J Pancreas (Online) 2010; 11: 630-632
109. Uomo I, Miraglia S, Pastorello M: Inflammation and Pancreatic Ductal
Adenocarcinoma: A Potential Scenario for Novel Drug Targets. J Pancreas Online) 2010; 11:
199-202
110. Pelletier AL, Hammel P, Rebours V, et al.: Acute pancreatitis in patients operated on for
intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and
clinicopathologic correlations.Pancreas. 2010;39:658-61
111. Aparicio JR, Martinez J, Niveiro M, et al. Direct intracystic biopsy and pancreatic
cystoscopy through a 19-gauge needle EUS. Gastrointest Endosc 2010; 72: 1285-1288.
112. Ringold AD, Yen RD, Chan YK. Direct dorsal pancreatoscopy with narrow band imaging
for the diagnosis of intraductal papillary mucinous neoplasm and pancreas divisum.
Gastrointest Endosc 2010; 72: 1163-1164.
113. Al-Haddad M, Gill KRS, Raimondo M, et al. Safety and efficacy of cytology brushing
versus standard fine-needle aspiration in evaluating cystic pancreatic lesions: a controlled
study. Endoscopy 2010; 42: 127-132.
114. Sahai AV. The role of EUS for diagnosis of pancreatic cysts: observe, needle, or brush?
Endoscopy 2010; 42: 153-154.
115. Kumon RE, Pollack MJ, Faulx AL, et al. In vivo characterisation of pancreatic and lymph
node tissue by using EUS spectrum analysis: a validation study. Gastrointest Endosc 2010; 71:
53-63.
116. Sahai AV, Paquin SC, Gariépy G. A prospective comparison of endoscopic ultrasoundguided fine needle aspiration results obtained in the same lesion, with and without the needle
stylet. Endoscopy. 2010; 42: 900-903.
117. Lee SH, Ozden N, Pawa R, et al. Periductal hypoechoic sign: an endosonographic finding
associated with pancreatic malignancy. Gastrointest Endosc 2010; 71: 249-255.
118. Affronti J. What the heck is this new periductal hypoechoic sign? Gastrointest Endosc
2010; 71: 256-259.
119. Benson ME, Byrne S, Brust DJ, et al. EUS and ERCP complication rates are not
increased in elderly patients. Dig Dis Sci. 2010; 55: 3278-3283.
120. Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS
and FNA: a report of accuracy. Gastrointest Endosc 2010; 71: 91-98.
121. Cherian PT, Mohan P, Douiri A, et al. Role of endoscopic ultrasound-guided fine-needle
aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: is onsite
cytopathology necessary? HPB (Oxford). 2010; 12: 389-395.
122. DeWitt J, Sherman S, Al-Haddad M, et al. EUS-guided FNA of local recurrence after
pancreatic cancer surgical resection. Gastrointest Endosc 2010; 72: 1076-1080.
123. Napoleon B, Alvarez-Sanchez MV, Gincoul R, et al. Contrast-enhanced harmonic
endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy
2010; 42: 564-570.
124. Ishikawa T, Itoh A, Kawashima H, et al. Usefulness of EUS combined with contrastenhancement in the differential diagnosis of malignant versus benign and preoperative
localization of pancreatic endocrine tumors. Gastrointest Endosc 2010; 71: 951-959.
125. Diehl DL, Blansfield J, Li J. Cystic pancreatic neuroendocrine tumor. Gastrointest
Endosc 2010; 71: 1064-1065.
126. Khashab M, Mokadem M, DeWitt J, et al. Endoscopic ultrasound-guided fine-needle
aspiration with or without flow cytometry for the diagnosis of primary pancreatic lymphoma –
a case series. Endoscopy 2010; 42: 228-231.
127. Pinto-Marques P, Martins C, Mendonca E, et al. Pancreatic head mass of unusual
etiology: multiple myeloma diagnosed by endoscopic ultrasound-guided fine needle aspiration.
Endoscopy 2010; 42: Suppl 2:E263-264.
128. Matsumoto K, Hara K, Sawaki A, et al. Ruptured pseudoaneurysm of the splenic artery
complicating endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic
cancer. Endoscopy 2010; 42 Suppl 2: E27-28.
129. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for
cancer of the head of the pancreas. N Engl J Med. 2010; 362: 129-137.
130. Boulay BR, Gardner TB, Gordon SR. Occlusion rate and complications of plastic biliary
stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer
with malignant biliary obstruction. J Clin Gastroenterol. 2010; 44: 452-455. Comment in: J
Clin Gastroenterol. 2010; 44: 389-390.
131. Lennon AM, Newman N, Makary MA, et al. EUS-guided tattooing before laparoscopic
distal pancreatic resection. Gastrointest Endosc 2010; 72: 1089-1094.
132. Newman NA, Lennon AM, Edil BH, et al. Preoperative endoscopic tattooing of pancreatic
body and tail lesions decreases operative time for laparoscopic distal pancreatectomy. Surgery.
2010; 148: 371-377.
133. Rieder B, Krampulz D, Adolf J, et al. Endoscopic pancreatic sphincterotomy and stenting
for preoperative prophylaxis of pancreatic fistula after distal pancreatectomy. Gastrointest
Endosc 2010; 72: 536-542.
134. Dumonceau JM. Distal pancreatectomy: another indication for prophylactic pancreatic
stenting? Gastrointest Endosc 2010; 72: 543-545.
135. Park WG, Yan BM, Schellenberg D, et al. EUS-guided gold fiducial insertion for imageguided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy.
Gastrointest Endosc 2010; 71: 513-518.
136. Ammar T, Coté GA, Creach KM, et al. Fiducial placement for stereotactic radiation by
using EUS: feasibility when using a marker compatible with a standard 22-gauge needle.
Gastrointest Endosc 2010; 71: 630-633.
137. Miura T, Igarashi Y, Okano N, et al. Endoscopic diagnosis of intraductal papillarymucinous neoplasm of the pancreas by means of peroral pancreatoscopy using a smalldiameter videoscope and narrow-band imaging. Dig Endosc. 2010; 22: 119-123.
138. Shimizu M, Kawaguchi A, Nagao S, et al. A case of intraductal papillary mucinous
neoplasm of the pancreas rupturing both the stomach and duodenum. Gastrointest Endosc
2010; 71: 406-412.
139. Haugk B. Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer?
Histopathology 2010;503-514.
140. Verna EC. Pancreatic cancer screening in a prospective cohort of high-risk patients: a
comprehensive strategy of imaging and genetics Clin Cancer Res 2010;16(20):5028-5037.
141. Correa-Gallego C et al. Incidental pancreatic cysts: do we really know what we are
watching? Pancreatology 2010;10:144-150.
142. Imai H et al. Preoperative assessment of paraaortic lymph node metastasis in patients
with pancreatic cancer Int J Clin Oncol 2010;15:294-300.
143. Jarboe EA et Layfield LJ. Cytologic features of panceatic intraepithelial neoplasia and
pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma. Diagn
Cytopathol 2010;38:[epub ahead of print]
144. Clark CJ et al. Positive peritoneal lavage cytology is a predictor of worse survival in
locally advanced pancreatic cancer. Am J Surg 2010;199:657-662.
145. Wakatsuki T et al. Complete response of anaplastic pancreatic carcinoma to treatment
selected by chemosensitivity testing. Int J Clin Oncol 2010;15:310-313.
146. Burford H et al. E-cadherin/β-catenin and CD10 A limited immunohistochemical panel
to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the
pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas. Am J Clin
Pathol 2009;132:831-839.
147. Rossi ED et al. Endoscopic ultrasound-guided fine-needle aspiration with liquid-based
cytologyc preparation in the diagnosis of primary pancreatic lymphoma. Pancreas
2010;39:1299-1302
148. Ikenaga N et al. CD10+ pancreatic stellate cells enhance the progression of pancreatic
cancer Gastroenterol 2010;139:1041-1051.
149. Partelli S et al. Intraductal papillary mucinous carcinomas of the pancreas Ann Surg
2010;251:477-482.
150. Ikeuchi N et al. Prognosis of cancer with branch duct type IPMNof the pancreas World J
Gastroenterol 2010;16(15):1890-1895.
151. Takasu N et al. Intraductal papillary-mucinous neoplasms of the gastric and intestinal
types may have less malignant potential than the pancreatobiliary type Pancreas 2010;39:604-
610.
152. Ikenaga N et al. Characterisation of CD24 expression in intraductal papillary mucinous
neoplasms and ductal carcinoma of the pancreas Hum Pathol 2010; 41:1466-1474
153. Sun HY al. CT imaging spectrum of pancreatic serous tumors: based on new pathologic
classification Europ J Radiol 2010;14:45-55.
154. Klöppel G et al. The ENETS and AJCC/UICC TNM classifications of the
neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement Virchows
Arch 2010;456:595-597.
155. Franko J et al. Non-functional neuroendocrine carcinoma of the pancreas: incidence,
tumor biology, and outcomes in 2158 patients J Gastrointest Surg 2010;14:541-548.
156. Romics L al. Solid pseudopapillary neoplasm of the pancreas – proposed algorithms for
diagnosis and surgical treatment Langenbecks Arch Surg 2010;395:747-755.
157. Konstantinidis IT et al. Metastatic tumors in the pancreas in the modern era J Am Coll
Surg 2010;211:749-753.
158. Kim YC, Choi J-Y, Chung YE,,et al. Comparison of MRI and Endoscopic Ultrasound in
the Characterization of Pancreatic Cystic Lesions AJR 2010
159. Takanami K, Yamada T, Tsuda M, et al Intraductal papillary mucininous neoplasm of the
bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging (2010)
160. Sun HY, Kim SH, Kim MA, et al. CT imaging spectrum of pancreatic serous tumors:
Based on new pathologic classification. European Journal of Radiology 75 (2010) e45–e55
161. Hsu M-Y, Pan K-T, Chu S-Y, et al. CT and MRI features of acinar cell carcinoma of the
pancreas with pathological correlations Clinical Radiology 65 (2010) 223–229
162. Yu MH, Lee JY, Kim MA, et al. MR Imaging Features of Small Solid Pseudopapillary
Tumors: Retrospective Differentiation From Other Small Solid Pancreatic Tumors
163. Macari M, Spieler B, Kim D, et al. Dual-Source Dual-Energy MDCT of Pancreatic
Adenocarcinoma: Initial Observations With Data Generated at 80 kVp and at Simulated
Weighted-Average 120 kVp AJR 2010
164. Morgan DE., Waggoner CN, Canon CL, et al.Mark Resectability of Pancreatic
Adenocarcinoma in Patients with Locally Advanced Disease Downstaged by Preoperative
Therapy: A Challenge for MDCT AJR 2010
165. Deshmukh1 SD, Willmann JK, Jeffrey RB, et al. Pathways of Extrapancreatic Perineural
Invasion by Pancreatic Adenocarcinoma: Evaluation With 3D Volume-Rendered MDCT
Imaging AJR 2010
166. Goldberg J, Rosenblat J, Khatri G, et al. Complementary Roles of CT and Endoscopic
Ultrasound in Evaluating a Pancreatic Mass AJR 2010
167. Baek JH, Lee JM, Kim SH, et al. Soo Small (3 cm) Solid Pseudopapillary Tumors of the
Pancreas at Multiphasic Multidetector CT Radiology: Volume 257: Number 1—October 2010
168. Lewis Rachel B, Lattin GE Jr, Paal E. Pancreatic Endocrine Tumors: RadiologicClinicopathologic Correlation RadioGraphics 2010; 30:1445–1464.
169. Orsi F, Zhang L, Arnone P, et al. High-Intensity Focused Ultrasound Ablation: Effective
and Safe Therapy for Solid Tumors in Difficult Locations AJR 2010; 195:W245–W252
170. Petrone MC, Arcidiacono PG, Carrara, S, et al US-guided application of a new hybrid
probe in human pancreatic adenocarcinoma: an ex vivo study GASTROINTESTINAL
ENDOSCOPY Volume 71, No. 7 : 2010
171. Hurtuk MG, Shoup M, Oshima K, et al.: Pancreaticoduodenectomies in patients without
periampullary neoplasms: lesions that masquerade as cancer. Am J Surg. 2010; 199:372-6
172. Dite P, Novotny I, Precechtelova M, et al.: Incidence of pancreatic carcinoma in patients
with chronic pancreatitis. Hepatogastroenterology. 2010;57:957-60
173. Oliverius M, Kala Z, Varga M, et al.: Radical surgery for pancreatic malignancy in the
elderly. Pancreatology. 2010;10:499-502
174. Schiffman SC, Chu CK, Park J, et al.: Is prior cholecystectomy associated with
decreased survival in patients with resectable pancreatic adenocarcinoma following
pancreaticoduodenectomy. Am J Surg. 2010; Sep 21 (Epub ahead of print)
175. Eshuis WJ, van der Gaag NA, Rauws EA, et al.: Therapeutic delay and survival after
surgery for cancer of the pancreatic head with or without preoperative biliary drainage.
Ann Surg. 2010; 252:840-9
176. Jamieson NB, Foulis AK, Oien KA, et al.: Positive mobilization margins alone do not
onfluence survival following pancreatico-duodenectomy for pancreatic ductal
adenocarcinoma. Ann Surg. 2010; 251:1003-10
177. Clark CJ, Traverso LW.: Positive peritoneal lavage cytology is a predictor of worse
survival in locally advanced pancreatic cancer. Am J Surg. 2010; 199:657-62
178. Sperti C, Berselli M, Pedrazzoli S.: Distal pancreatectomy for body-tail pancreatic cancer:
is there a role for celiac axis resection? Pancreatology. 2010; 10:491-8
179. Bockhorn M, Burdelski C, Bogoevski D, et al.: Arterial en bloc resection for pancreatic
carcinoma. Br J Surg. 2010; Oct 25. (Epub ahead of print)
180. Girelli R, Frigerio I, Salvia R, et al.: Feasibility and safety of radiofrequency ablation for
locally advanced pancreatic cancer. Br J Surg. 2010; 97:220-5
181. Kayahara M, Funaki K, Tajima H, et al.: Surgical implication of micrometastasis for
pancreatic cancer. Pancreas. 2010; 39:884-8
182. De Jong MC, Farnell MB, Sclabas G, et al.: Liver-directed therapy for hepatic
metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg.
2010; 252:142-8
183. Mansfield A, Tafur A, Smithedajkul P, et al.: Mayo Clinic experience with very rare
exocrine pancreatic neoplasms. Pancreas. 2010; 39:972-5
184. Zerbi A, Falconi M, Rindi G, et al.: Clinicopathological features of pancreatic endocrine
tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol.
2010; 105:1421-9
185. Casadei R, Ricci C, Rega D, et al.: Pancreatic endocrine tumors less than 4 cm in
diameter: resect or enucleate? a single-center experience. Pancreas. 2010; 39:825-8
186. Casadei R, Ricci C, Pezzilli R, et al.: Are there prognostic factors related to recurrence in
pancreatic endocrine tumors? Pancreatology. 2010; 10:33-8
187. Fitzmaurice C, Seiler CM, Büchler MW, et al.: Survival, mortality and quality of life
after pylorus-preserving or classical Whipple operation. A systematic review with metaanalysis. Chirurg. 2010;81:454-71
188. Gaujoux S, Cortes A, Cuvelard A, et al.: Fatty pancreas and increased body mass index
are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15-23
189. Kuroki T, Tajima Y, Kitasato A, et al.: Stenting versus non-stenting in
pancreaticojejunostomy: A prospective study limited to a normal pancreas without fibrosis
sorted by using dynamic MRI. Pancreas. 2010 Aug 14. (Epub ahead of print)
190. Tani M, Kawai M, Hirono S, et al.: A prospective randomized controlled trial of internal
versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy. Am J
Surg. 2010;199:759-64
191. Shukla PJ, Barreto SG, Fingerhut A.: Do transanastomotic pancreatic ductal stents after
pancreatic resections improve outcomes? Pancreas. 2010;39:561-6
192. Bassi C, Molinari E, Malleo G, et al.: Early versus late drain removal after standard
pancreatic resections: results of a prospective randomized trial. Ann Surg. 2010;252:207-14
193. Diener MK, Mehr KT, Wente MN, et al.: Risk-benefit assessment of closed intraabdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing
the current state of evidence. Langenbecks Arch Surg. 2011; 396:41-52
194. Zhou W, Lv R, Wang X, et al.: Stapler vs suture closure of pancreatic remnant after distal
pancreatectomy: a meta-analysis.Am J Surg. 2010. 200:529-36
195. Gehrig T, Müller-Stich BP, Kenngott H, et al.: LigaSure versus conventional dissection
technique in pancreatoduodenectomy: pilot study. Am J Surg. 2010 Sep 22. (Epub ahead of
print)
196. Rosok BI, Marangos IP, Kazaryan AM, et al.: Single-centre experience of laparoscopic
pancreatic surgery. Br J Surg. 2010;97:902-9
197. Li D, Abbruzzese JL: New Strategies in PancreaticCancer: Emerging Epidemiologic and
Therapeutic Concepts Clin. Cancer Res., Sep 2010; 16: 4313 – 4318.
198. Klapdor R, Bahlo M, Babinski A, et al. CA19-9 Serum Concentrations – Analysis of the
Serum Kinetics During First-line Therapy of PancreaticCancer in Relation to Overall
Survival Anticancer Res, May 2010; 30: 1869 – 1874.
199. Boeck S, Haas M, Laubender RP, et al. Application of a Time-Varying Covariate Model
to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced PancreaticCancer
Clin. Cancer Res., Feb 2010; 16: 986 – 994.
200. Matsubara J, Ono M, Honda K, et al. Survival Prediction for Pancreatic Cancer Patients
Receiving Gemcitabine Treatment Mol. Cell. Proteomics, Apr 2010; 9: 695 – 704.
201. Mancuso A, Sacchetta S, Saletti PC, et al. Clinical and Molecular Determinants of
Survival in PancreaticCancer Patients Treated with Second-line Chemotherapy: Results of an
Italian/Swiss Multicenter Survey Anticancer Res, October 2010; 30: 4289 – 4295
202. Roy R, Maraveyas A. Chemoradiation in Pancreatic Adenocarcinoma: A Literature
Review Oncologist, Mar 2010; 15: 259 – 269.
203. Ko AH, Crane CH. Radiation Therapy in Operable and Locally Advanced
PancreaticCancer J Natl Compr Canc Netw, September 2010; 8: 1022 – 1031.
204. Kim EJ, Ben-Josef, Griffith K et al. Phase II trial of neoadjuvant full dose Gemcitabine,
Oxaliplatin and radiation in patients with resectable or borderline resectable pancreatic cancer
J Clin Oncol 2011 Gastrointestinal Cancers Symposium. Vol 29, No 4_suppl (February 1
Supplement), 2011: 239
205. Hosein PJ, Kawamura C, MacInyre J, et al. Pilot study of neoadjuvant FOLFIRINOX in
locally advanced pancreatic carcinoma ). J Clin Oncol, 2011 Gastrointestinal Cancers
Symposium.Vol 29, No 4, 2011: 324
206. Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant Chemotherapy With Fluorouracil
Plus Folinic Acid vs Gemcitabine Following PancreaticCancer Resection: A Randomized
Controlled Trial JAMA, September 8, 2010; 304: 1073 – 1081.
207. Yang R, Cheung MC, Byrne MM, et al. Survival Effects of Adjuvant Chemoradiotherapy
After Resection for Pancreatic Carcinoma Arch Surg, Jan 2010; 145: 49 – 56.
208. Van Laethem JL, Hammel P, Mornex F, et al. Adjuvant Gemcitabine Alone Versus
Gemcitabine-Based Chemoradiotherapy After Curative Resection for PancreaticCancer: A
Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study J. Clin. Oncol.,
Oct 2010; 28: 4450 – 4456.
209. Berlin J , P. J. Catalano PJ, Y. Feng Y, ECOG 2204: An intergroup randomized phase II
study of cetuximab (Ce) or bevacizumab (B) in combination with gemcitabine (G) and in
combination with capecitabine (Ca) and radiation (XRT) as adjuvant therapy (Adj Tx) for
patients (pts) with completely resected pancreatic adenocarcinoma (PC). Journal of Clinical
Oncology, 2010 ASCO Vol 28, No 15_suppl (May 20 Supplement), 2010: 4034
210. Picozzi VJ, Abrams RA, Decker PA, Multicenter phase II trial of adjuvant therapy for
resected pancreaticcancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based
chemoradiation: ACOSOG Trial Z05031 Ann. Onc., February 2011; 22: 348 – 354.
211. Dahan L, Bonnetain F, Ychou M, Combination 5-fluorouracil, folinic acid and cisplatin
(LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic
cancer: final results of a randomised strategic phase III trial (FFCD 0301) Gut, Nov 2010; 59:
1527 – 1534.
212. Milella M, Gelibter AJ, Pino MS, et al. Fixed-Dose-Rate Gemcitabine: A Viable FirstLine Treatment Option for Advanced Pancreatic and Biliary Tract Cancer Oncologist, Feb
2010; 15: e1 – e4.
213. Hess V, Pratsch S, Potthast S, et al. Combining gemcitabine, oxaliplatin and
capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase
I/II trial Ann. Onc., December 2010; 21: 2390 – 2395.
214. De Jesus-Acosta A, Oliver GR, Flores E, A multicenter review of gemcitabine,
docetaxel, and capecitabine (GTX) in patients with advanced pancreatic adenocarcinoma. J
Clin Oncol 2010 ASCO Annual Meeting Proceedings Vol 28, No 15_suppl , 2010: e14580
215. Colucci G, Labianca R, Di Costanzo F, et al. Randomized Phase III Trial of
Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line
Treatment of Patients With Advanced PancreaticCancer: The GIP-1 Study J. Clin. Oncol.,
Apr 2010; 28: 1645 – 1651
216. Melnik MK, Webb CP, Richardson PJ, et al. Phase II Trial to Evaluate Gemcitabine and
Etoposide for Locally Advanced or Metastatic Pancreatic Cancer Mol. Cancer Ther., Aug
2010; 9: 2423 – 2429
217. Yukisawa S, Ishii H, Matsuyama M, et al. Outcomes and Tolerability of Systemic
Chemotherapy for Pancreatic or Biliary Cancer Patients Aged 75 Years or Older Jpn. J. Clin.
Oncol. January 2011; 41: 76 – 80.
218. Christman-Skieller C, Heestand GM, Fisher GA. Treatment of pancreatic cancer in
patients age 70 or older. J Clin Oncol 2010 ASCO Annual Meeting Proceedings Vol 28, No
15_suppl 2010: e14590
219. Philip PA, Benedetti J, Corless CL, et al. Phase III Study Comparing Gemcitabine Plus
Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma:
Southwest Oncology Group–Directed Intergroup Trial S0205 J. Clin. Oncol., Aug 2010; 28:
3605 – 3610.
220. Boeck S, Heinemann V. Anti–Epidermal Growth Factor Receptor Treatment Strategies in
Advanced PancreaticCancer: Success or Failure? J. Clin. Oncol., Dec 2010;
doi:10.1200/JCO.2010.31.8733
221. Mahipal A, McDonald MJ, Witkiewicz A, Epidermal growth factor receptor
overexpression in resected pancreatic cancer. J Clin Oncol, 2011 Gastrointestinal Cancers
Symposium.Vol 29, No 4, 2011:317
222. Kindler HL, Niedzwiecki D, Hollis D, Gemcitabine Plus Bevacizumab Compared With
Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of
the Cancer and Leukemia Group B (CALGB 80303) J Clin Oncol Aug 1, 2010:3617-3622
223. Geissler M, Hofheinz R, Moehler MH. Trastuzumab and capecitabine in patients with
HER2-expressing metastatic pancreatic cancer: A multicenter phase II study of the German
AIO Pancreatic Cancer Group (AIO PK-0204). J Clin Oncol, 2010 ASCO Annual Meeting
Proceedings Vol 28, No 15_suppl, 2010: 4070
224. McDermott RS, Calvert P, Parker M, A phase II study of lapatinib and capecitabine in
first-line treatment of metastatic pancreatic cancer (ICORG 08- 39). J Clin Oncol 2011
Gastrointestinal Cancers Symposium. Vol 29, No 4_suppl (February 1 Supplement), 2011:
315
225. Sacoff WH, Reber HA, Purcell FM, Low-dose continuous infusion 5-fluorouracil
combined with weekly leucovorin, nab-paclitaxel, oxaliplatin, and bevacizumab for patients
with advanced pancreatic cancer: A pilot study. J Clin Oncol, 2010 ASCO Annual Meeting
Proceedings Vol 28, No 15_suppl, 2010: e14545
226. Olgar SC, Méndez CM, Fernández MJ, A phase II study of capecitabine in combination
with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV). J
Clin Oncol, 2011 Gastrointestinal Cancers Symposium.Vol 29, No 4, 2011: 277
227. Cohen DJ, Leichman LP, Love E, Phase II study of sorafenib with gemcitabine and
erlotinib (GES) in first-line advanced pancreatic cancer. J Clin Oncol, 2011 Gastrointestinal
Cancers Symposium.Vol 29, No 4, 2011:266
228. Munoz A, Mane JM, Lopez-Vivanco G, et al. Gemcitabine (G) fixed dose rate (FDR)
infusion plus Erlotinib (E) in patients with advanced pancreatic cancer (APC) J Clin Oncol,
2011 Gastrointestinal Cancers Symposium.Vol 29, No 4, 2011:
229. Lu J, Deng H, Tang R, Exposure-response (E-R) analysis to facilitate phase III (P3) dose
selection for AMG 479 (A479) in combination with gemcitabine (G) to treat metastatic
pancreatic cancer (mPC). J Clin Oncol, 2011 Gastrointestinal Cancers Symposium.Vol 29,
No 4, 2011: 263
230. Ocean AJ, Guarino MJ, Pennington KL, Activity of fractionated radioimmunotherapy
with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced
pancreatic cancer (APC). ). J Clin Oncol, 2011 Gastrointestinal Cancers Symposium.Vol 29,
No 4, 2011:240
231. Larbouret C, Robert B, Bascoul-Mollevi C, et al. Combined cetuximab and trastuzumab
are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts Ann.
Onc., January 2010; 21: 98 – 103.
232. Huang J, Robertson JM, Margolis J, et al: Long-term results of full-dose Gemcitabine
with radiation therapy compared to 5-Fluorouracil with radiation therapy for locally advanced
pancreatic cancer J Clin Oncol, 2011 Gastrointestinal Cancers Symposium.Vol 29, No 4,
2011:287
233. Palmeri M, Pipas M, Ripple et al. Intensity-Modulated Radiation Therapy (IMRT) in
pancreatic adenocarcinoma: The Dartmouth-Hitchcock Medican Center Experience J Clin
Oncol, 2011 Gastrointestinal Cancers Symposium.Vol 29, No 4, 2011:274
234. Christensen M, Paximadis P, Shields AF, et al. Mixed photon and Neutron radiotherapy
given concurrently with chemotherapy in unresectable pancreatic cancer. J Clin Oncol, 2011
Gastrointestinal Cancers Symposium.Vol 29, No 4, 2011: 328
235. Assaf E, Verlinde-Carvalho M, Delbaldo C, 5-FU/leucovorin (5FU/LV) combined with
irinotecan (CPT-11) and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients
with metastatic pancreatic adenocarcinoma. J Clin Oncol, 2010 ASCO Annual Meeting
Proceedings Vol 28, No 15_suppl, 2010: e14584
236. Todaka A, Fukutomi A, Boku N, et al. S-1 Monotherapy as Second-line Treatment for
Advanced PancreaticCancer after Gemcitabine Failure Jpn. J. Clin. Oncol., June 2010; 40:
567 – 572.
237. Shukuya T, Jasui H, Boku H, et al. eekly Paclitaxel After Failure of Gemcitabine in
PancreaticCancer Patients with Malignant Ascites: A Retrospective Study Jpn. J. Clin. Oncol.,
December 2010; 40: 1135 – 1138.
238. Wasif Saif M, Syrgios K, Penney R, et al. Docetaxel Second-line Therapy in Patients with
Advanced Pancreatic Cancer: A Retrospective Study Anticancer Res, July 2010; 30: 2905 –
2909
239. O’Reilly EM, Niedzwiecki D, Hall M, et al. A Cancer and Leukemia Group B Phase II
Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic
Adenocarcinoma (CALGB 80603) Oncologist, Dec 2010; 15: 1310 – 1319.
240. Cereda S, Reni M, Rognone A, et al. XELIRI or FOLFIRI as salvage therapy in advanced
pancreatic cancer Anticancer Res Nov 2010 30:4785-90
241. Chabot JA, Tsai WJ, Fine RL, et al Pancreatic Proteolytic Enzyme Therapy Compared
With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer J. Clin.
Oncol., Apr 2010; 28: 2058 – 2063
242. Maetani I, Nambu T, Omuta S, et al. Treating bilio-duodenal obstruction: combining new
endoscopic technique with 6 Fr stent introducer. World J Gastroenterol. 2010; 16: 2828-2831.
243. Chauvin A et al. Upper gastrointestinal bleeding from Brunner’s gland hamartoma Dig
Liver Dis 2010;xxx-xxx.
244. Hayashi T et al. Total replacement of the exocrine pancreas with fat following multiple
blunt injuries Med Sci Law 2010;50:103-106.
245. Altinel D et al. Lipomatous pseudohypertrophy of the pancreas: a clinicopathologically
dictinct entity Pancreas 2010;39:392-397.
246. Scudiere JR et al. Sclerosing mesenteritis involving the pancreas: a mimicker of
pancreatic cancer Am J Surg Pathol 2010;34:447-453.
247. Padhi S et al. Extragastrointestinal stromal tumor arising in the pancreas: a case report
with a review of the literature JOP 2010;11:244-248.
248. Espinal-Witter R et al. Localized intrapancreatic malignant mesothelioma: a rare entity
that may be confused with other pancreatic neoplasms Virchows Arch 2010;456:455-461.
249. Hirabayashi K et al. First case of primary phylloides tumor of the pancreas: case report
and findings of immunohistochemical and ultrastructural studies Virchows Arch
2010;456:587-593.
250. Charalabopoulos A et al. Localized peripancreatic plasma cell Castleman disease Am J
Surg 2010;199:e51-e53.
251. Daniel SV et al. Obstructive jaundice due to a pancreatic mass: a rare presentation of
acute lymphoblastic leukemia in an adult JOP 2010;11:72-74.
252. Kung JW, Brown A, Kruskal JB, et al. Heterotopic pancreas: typical and atypical
imaging findings Clinical Radiology 65 (2010) 403–407
253. Yang DM, Kim HC, Ryu JK, et al. Sonographic Appearance of Focal Fatty Infiltration
of the Pancreas J Clin Ultrasound 38:45–47, 2010
254. Sequeiros IM, Hester K, Callaway M , et al. MRI appearance of the pancreas in patients
with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients
British Journal of Radiology (2010)
255. Rekhi S, Anderson SW, Rhea JT, et al. Imaging of blunt pancreatic trauma Emerg
Radiol (2010) 17:13–19
